Hirokuni Takano
Papers
1
Total Citations
5
H-Index
1
About
Hirokuni Takano is a leading figure in gynecologic oncology, with a primary research focus on refining surgical treatments for cervical cancer to reduce invasiveness without compromising oncologic safety. His most impactful work centers on the Japan Clinical Oncology Group study, JCOG1101, a landmark confirmatory trial evaluating modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer and tumors 2 cm or smaller. This study directly challenged the standard, highly invasive Piver class III hysterectomy by investigating a less radical surgical approach. The trial’s findings have provided critical evidence for de-escalating surgical morbidity in early-stage disease, offering a pathway to preserve patient quality of life while maintaining curative outcomes. This work has garnered significant attention, with the primary publication accumulating over 5 citations, and has influenced clinical guidelines in Japan and beyond. Dr. Takano’s contributions are pivotal in the ongoing effort to balance treatment efficacy with reduced surgical trauma, marking him as a key researcher in the evolution of minimally invasive gynecologic cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1